Uncategorized
Kala Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for INVELTYSTM (KPI-121 1%)
WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for INVELTYS (KPI-121 1%).